Direct positive image forming method
    3.
    发明授权
    Direct positive image forming method 失效
    直接正成像法

    公开(公告)号:US4994364A

    公开(公告)日:1991-02-19

    申请号:US394386

    申请日:1989-08-15

    IPC分类号: G03C1/07 G03C1/485 G03C7/00

    CPC分类号: G03C1/48561 Y10S430/141

    摘要: A direct positive image forming method comprising development processing an imagewise exposed direct positive photographic light-sensitive material which comprises a support having thereon at least one layer containing internal latent image type silver halide grains not having been previously fogged after fogging treatment or while fogging treatment, wherein the fogging treatment is conducted in the presence of a compound represented by the following general formula (I): ##STR1## wherein A.sub.1 and A.sub.2 both represent a hydrogen atom or one of A.sub.1 and A.sub.2 represents a hydrogen atom and the other represents a sulfonyl group or an acyl group; G.sub.1 represents a carbonyl group, a sulfonyl group, a sulfoxy group, ##STR2## or an iminomethylene group; L.sub.1 represents a divalent linkage group; X.sub.1 represents --O-- or ##STR3## wherein R.sub.4 represents a hydrogen atom, an alkyl group or an aryl group); Y.sub.1 represents ##STR4## R.sub.1 and R.sub.2 each represents an aliphatic group, an aromatic group, a heterocyclic group, --OR.sub.5 or --NR.sub.5 R.sub.6 (wherein R.sub.5 represents an aliphatic group, an aromatic group or a heterocyclic group; and R.sub.6 represents a hydrogen atom, an aliphatic group, an aromatic group or a heterocyclic group); and R.sub.3 represents a hydrogen atom, an alkyl group, an aryl group, an alkoxy group, an aralkyl group, an aryloxy group or an amino group.In accordance with the method of the present invention direct positive images having a high maximum image density and a low minimum image density and being stable even when preserved under high temperature and high humidity conditions.

    Method for forming a direct positive color image
    4.
    发明授权
    Method for forming a direct positive color image 失效
    用于形成直接正彩色图像的方法

    公开(公告)号:US4956267A

    公开(公告)日:1990-09-11

    申请号:US200268

    申请日:1988-05-31

    IPC分类号: G03C1/485 G03C7/413

    CPC分类号: G03C7/413 G03C1/48538

    摘要: A method for forming a direct positive color image by image-wise exposing to light a light-sensitive material having at least one internal latent image type silver halide emulsion layer which is unfogged and color image-forming couplers on a support; either (1) subjecting the resulting material to fogging exposure to light and/or processing it with a nucleating agent before development, and then developing the resulting material with a surface developing solution containing an aromatic primary amine type color developing agent, or (2) developing the material after the image-wise exposure with a surface developing solution containing an aromatic primary amine type color developing agent under fogging exposure and/or in the presence of a nucleating agent; and bleach-fixing the resulting material, wherein the color developing solution contains at least one compound selected from the group consisting of compounds represented by the following general formulae (I), (II), (III) and (IV): ##STR1## wherein X represents --CO--, --SO.sub.2 -- or ##STR2## and R.sup.1 and R.sup.2 represents various familiar group; ##STR3## wherein R.sup.3, R.sup.4, R.sup.5 and R.sup.6 represent various familiar groups; ##STR4## wherein R.sup.7 and R.sup.8 represent various familiar groups; ##STR5## wherein Y represents a trivalent atomic group necessary for completing a condensed ring, m represents an integer of 0 to 4, and n represents an integer of 1 to 5.Stability of the color developing solutions with time lapse is excellent, which makes stable continuous process of color photographic light-sensitive materials possible over a long period.

    NOVEL CONDENSED PYRIDINE OR CONDENSED PYRIMIDINE DERIVATIVE, AND MEDICINAL AGENT COMPRISING SAME
    6.
    发明申请
    NOVEL CONDENSED PYRIDINE OR CONDENSED PYRIMIDINE DERIVATIVE, AND MEDICINAL AGENT COMPRISING SAME 有权
    新型浓缩的吡啶或稠合的吡啶衍生物,以及包含其的药物

    公开(公告)号:US20130102621A1

    公开(公告)日:2013-04-25

    申请号:US13806940

    申请日:2011-06-24

    摘要: The present invention relates to provision of a novel compound that has an activity of promoting insulin secretion from pancreatic β cells and thus is useful as a prophylaxis and/or therapeutic agent for diseases caused by hyperglycemia such as diabetes mellitus, andthe compound represented by the following formula (1): wherein one of A and B represents a nitrogen atom and the other represents a nitrogen atom or CR10, X represents an oxygen atom, a sulfur atom or —(CH2)n-N(R12)—, Y represents an oxygen atom, a sulfur atom or —N(R13)—, and R1 to R9 each represent a hydrogen atom or another substituent, or a salt thereof, or a solvate of the compound or the salt.

    摘要翻译: 本发明涉及提供具有促进胰β细胞胰岛素分泌的活性的新型化合物,因此可用作由高血糖引起的疾病如糖尿病的预防和/或治疗剂,以及由 下式(1):其中A和B之一表示氮原子,另一个表示氮原子或CR 10,X表示氧原子,硫原子或 - (CH 2)n N(R 12) - ,Y表示氧 原子,硫原子或-N(R 13) - ,并且R 1至R 9各自表示氢原子或其它取代基,或其盐,或化合物或其盐的溶剂合物。

    Electric motor control apparatus
    7.
    发明授权
    Electric motor control apparatus 有权
    电动机控制装置

    公开(公告)号:US07990093B2

    公开(公告)日:2011-08-02

    申请号:US12279859

    申请日:2006-04-20

    IPC分类号: H02P7/00

    摘要: A control apparatus for a multiphase AC electric motor having an inverter includes a current control including an abnormal-state current controller; an abnormal-state detector that detects an abnormal state of any of a wire of an electric motor, a wire of an inverter, and a wire connecting the electric motor to the inverter as an abnormal phase; and an abnormal phase disconnect. The abnormal phase disconnect disconnects one or more of phases detected to be in an abnormal-state and the abnormal-state current controller generates an abnormal state voltage command in accordance with detection of an abnormal state, and uses phases other than the disconnected phases of the inverter to control individual currents of the phases, with the abnormal-state voltage command used as a multiphase voltage command.

    摘要翻译: 一种具有逆变器的多相交流电动机的控制装置包括:电流控制装置,包括异常电流控制器; 异常状态检测器,其检测电动机的线材,逆变器的线以及将电动机与逆变器连接的线的异常状态,作为异常相位; 和异常相断开。 异常相位断开断开检测到异常状态的一个或多个相位,异常状态电流控制器根据异常状态的检测产生异常状态电压指令,并且使用除 逆变器用于控制各相电流,异常状态电压指令用作多相电压指令。

    PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR HYPERLIPIDEMIA
    8.
    发明申请
    PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR HYPERLIPIDEMIA 有权
    高效药物和/或治疗药物

    公开(公告)号:US20100069433A1

    公开(公告)日:2010-03-18

    申请号:US12593356

    申请日:2008-03-28

    IPC分类号: A61K31/47 A61K31/42

    摘要: The present invention provides a therapeutic agent for hyperlipidemia having an excellent effect of lowering the cholesterol and triglyceride level in blood plasma.The present invention relates to a prophylactic and/or therapeutic agent for hyperlipidemia, a prophylactic and/or therapeutic agent for obesity or diabetes mellitus, and a prophylactic and/or therapeutic agent for metabolic syndrome, each agent including a compound represented by the following formula (1): , wherein: R1 and R2, which may be identical or different, each represent a hydrogen atom, a methyl group or an ethyl group; R3a, R3b, R4a and R4b, which may be identical or different, each represent a hydrogen atom, a halogen atom, a nitro group, a hydroxyl group, a C1-4 alkyl group, a trifluoromethyl group, a C1-4 alkoxy group, a C1-4 alkylcarbonyloxy group, a di-C1-4 alkylamino group, a C1-4 alkylsulfonyloxy group, a C1-4 alkylsulfonyl group, a C1-4 alkylsulfinyl group, or a C1-4 alkylthio group, or R3a and R3b, or R4a and R4b are joined to represent an alkylenedioxy group; X represents an oxygen atom, a sulfur atom or N—R5 (wherein R5 represents a hydrogen atom, a C1-4 alkyl group, a C1-4 alkylsulfonyl group, or a C1-4 alkyloxycarbonyl group); Y represents an oxygen atom, a S(O)l group (l represents a number from 0 to 2), a carbonyl group, a carbonylamino group, an aminocarbonyl group, a sulfonylamino group, an aminosulfonyl group, or an NH group; Z represents CH or N; n represents a number from 1 to 6; and m represents a number from 2 to 6, or a salt thereof, and a statin, particularly pitavastatin, in combination.

    摘要翻译: 本发明提供了具有降低血浆中胆固醇和甘油三酯水平的优异效果的高脂血症治疗剂。 本发明涉及高脂血症的预防和/或治疗剂,肥胖症或糖尿病的预防和/或治疗剂,以及代谢综合征的预防和/或治疗剂,每种试剂包括由下式表示的化合物 (1)表示:其中:R 1和R 2可以相同或不同,各自表示氢原子,甲基或乙基; R3a,R3b,R4a和R4b可以相同或不同,分别表示氢原子,卤素原子,硝基,羟基,C1-4烷基,三氟甲基,C1-4烷氧基 ,C 1-4烷基羰基氧基,二-C 1-4烷基氨基,C 1-4烷基磺酰氧基,C 1-4烷基磺酰基,C 1-4烷基亚磺酰基或C 1-4烷硫基,或R 3a和R 3b ,或R4a和R4b连接以代表亚烷基二氧基; X表示氧原子,硫原子或N-R5(其中,R5表示氢原子,C1-4烷基,C1-4烷基磺酰基或C1-4烷氧基羰基)。 Y表示氧原子,S(O)1基(l表示0〜2的数),羰基,羰基氨基,氨基羰基,磺酰基氨基,氨基磺酰基或NH基。 Z表示CH或N; n表示1〜6的数; m代表2至6的数,或其盐,他汀类,特别是匹伐他汀组合。

    Motor controller
    10.
    发明申请
    Motor controller 有权
    电机控制器

    公开(公告)号:US20070176577A1

    公开(公告)日:2007-08-02

    申请号:US10590931

    申请日:2005-03-16

    IPC分类号: H02P27/04

    摘要: A control apparatus for an electric motor, in which a current controller giving multiphase voltage commands to a drive circuit for an inverter includes a normal-mode current controller for use in a normal mode, an abnormal-mode current controller for use in an abnormal mode, and an abnormality decision device. In a case of an abnormality occurring to one phase of an electric motor or the inverter, the controller is altered, and the abnormal-mode multiphase voltage commands which are generated by the abnormal-mode current controller are set as the multiphase voltage commands for the inverter drive circuit.

    摘要翻译: 一种用于电动机的控制装置,其中向逆变器的驱动电路提供多相电压指令的电流控制器包括用于正常模式的正常模式电流控制器,用于异常模式的异常模式电流控制器 ,以及异常判定装置。 在电动机或逆变器的一相发生异常的情况下,改变控制器,将异常电流控制器产生的异常多相电压指令设定为多相电压指令 变频器驱动电路。